Source: Stockhead

KSS: ASX Tech & Biotech: Kleos launches new geospatial intelligence product, Radiopharm scores FDA approval

Kleos has released its new geospatial intelligence product to initial customers DC2 branches out from data centres with Attained acquisition ... Read More The post ASX Tech & Biotech: Kleos launches new geospatial intelligence product, Radiopharm scores FDA approval appeared first on Stockhead.

Read full article »
KSS's Competitors | KSS's News | KSS's Financials
Stay up-to-date with the latest news on Kleos
Annual Revenue
$ < 1M
Employees
22
Alan Khalili's photo - CEO of Kleos

CEO

Alan Khalili

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Kleos